Post by Incyte

Name: New data from the Phase 3 frontMIND trial in previously untreated, high-risk diffuse large B-cell ly
Uploaded: 2026-05-30T12:02:43.252Z
Channel: Incyte
Description: New data from the Phase 3 frontMIND trial in previously untreated, high-risk diffuse large B-cell lymphoma (DLBCL) patients was presented today at the American Society of Clinical Oncology (ASCO) Annu

144,099 followers

New data from the Phase 3 frontMIND trial in previously untreated, high-risk diffuse large B-cell lymphoma (DLBCL) patients was presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet Group. Read our press release to learn more. #ASCO26 https://bit.ly/49Pkkhx

Video Content